<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> associate <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> (arterial or venous), and presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, and require anticoagulation </plain></SENT>
<SENT sid="1" pm="."><plain>A catastrophic variant may develop, resulting in multiorgan failure, with high mortality rate </plain></SENT>
<SENT sid="2" pm="."><plain>This article presented a patient with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> presenting a catastrophic antiphospholipide syndrome after anticoagulation suspending for <z:hpo ids='HP_0002239'>gastrointestinal bleeding</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Multidisciplinary management in intensive care unit and aggressive therapies (<z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, anticoagulation, plasma exchange) were essential to rescue the patient </plain></SENT>
</text></document>